[3-(6-bromo-4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[3-[4-bromo-3-(trifluoromethyl)pyrazol-1-yl]pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(6-chloropyrazolo[5,4-b]pyridin-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;N-[1-(1H-imidazole-5-carbonyl)pyrrolidin-3-yl]cyclopropanecarboxamide;[(3R)-3-indazol-1-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-indazol-2-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone

C116H133Br2ClF5N35O8 — CID 158780325

IUPAC[3-(6-bromo-4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[3-[4-bromo-3-(trifluoromethyl)pyrazol-1-yl]pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(6-chloropyrazolo[5,4-b]pyridin-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;N-[1-(1H-imidazole-5-carbonyl)pyrrolidin-3-yl]cyclopropanecarboxamide;[(3R)-3-indazol-1-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-indazol-2-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone
SMILESCC(C)c1cc(C(=O)N2CCC(n3cc(Br)c(C(F)(F)F)n3)C2)n[nH]1.CC(C)c1cc(C(=O)N2CCC(n3ncc4c(F)cc(Br)cc43)C2)n[nH]1.CC(C)c1cc(C(=O)N2CC[C@@H](n3cc4ccccc4n3)C2)n[nH]1.CC(C)c1cc(C(=O)N2CC[C@@H](n3ncc4c(F)cccc43)C2)n[nH]1.CC(C)c1cc(C(=O)N2CC[C@@H](n3ncc4ccc(Cl)nc43)C2)n[nH]1.CC(C)c1cc(C(=O)N2CC[C@@H](n3ncc4ccccc43)C2)n[nH]1.O=C(NC1CCN(C(=O)c2cnc[nH]2)C1)C1CC1
InChIInChI=1S/C18H19BrFN5O.C18H20FN5O.2C18H21N5O.C17H19ClN6O.C15H17BrF3N5O.C12H16N4O2/c1-10(2)15-7-16(23-22-15)18(26)24-4-3-12(9-24)25-17-6-11(19)5-14(20)13(17)8-21-25;1-11(2)15-8-16(22-21-15)18(25)23-7-6-12(10-23)24-17-5-3-4-14(19)13(17)9-20-24;1-12(2)15-9-16(21-20-15)18(24)22-8-7-14(11-22)23-17-6-4-3-5-13(17)10-19-23;1-12(2)16-9-17(20-19-16)18(24)22-8-7-14(11-22)23-10-13-5-3-4-6-15(13)21-23;1-10(2)13-7-14(22-21-13)17(25)23-6-5-12(9-23)24-16-11(8-19-24)3-4-15(18)20-16;1-8(2)11-5-12(21-20-11)14(25)23-4-3-9(6-23)24-7-10(16)13(22-24)15(17,18)19;17-11(8-1-2-8)15-9-3-4-16(6-9)12(18)10-5-13-7-14-10/h5-8,10,12H,3-4,9H2,1-2H3,(H,22,23);3-5,8-9,11-12H,6-7,10H2,1-2H3,(H,21,22);3-6,9-10,12,14H,7-8,11H2,1-2H3,(H,20,21);3-6,9-10,12,14H,7-8,11H2,1-2H3,(H,19,20);3-4,7-8,10,12H,5-6,9H2,1-2H3,(H,21,22);5,7-9H,3-4,6H2,1-2H3,(H,20,21);5,7-9H,1-4,6H2,(H,13,14)(H,15,17)/t;12-;2*14-;12-;;/m.1111../s1
InChIKeyIQZKDBQLEGFWBE-JMSZYTPJSA-N
MW2435.83 g/mol
LogP19.69
Rot. Bonds21

About [3-(6-bromo-4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[3-[4-bromo-3-(trifluoromethyl)pyrazol-1-yl]pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(6-chloropyrazolo[5,4-b]pyridin-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;N-[1-(1H-imidazole-5-carbonyl)pyrrolidin-3-yl]cyclopropanecarboxamide;[(3R)-3-indazol-1-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-indazol-2-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone

[3-(6-bromo-4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[3-[4-bromo-3-(trifluoromethyl)pyrazol-1-yl]pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(6-chloropyrazolo[5,4-b]pyridin-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;N-[1-(1H-imidazole-5-carbonyl)pyrrolidin-3-yl]cyclopropanecarboxamide;[(3R)-3-indazol-1-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-indazol-2-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone (PubChem CID 158780325) has the molecular formula C116H133Br2ClF5N35O8 and a molecular weight of 2435.83 g/mol. Its IUPAC name is [3-(6-bromo-4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[3-[4-bromo-3-(trifluoromethyl)pyrazol-1-yl]pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(6-chloropyrazolo[5,4-b]pyridin-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;N-[1-(1H-imidazole-5-carbonyl)pyrrolidin-3-yl]cyclopropanecarboxamide;[(3R)-3-indazol-1-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-indazol-2-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone.

Molecular Properties

Compound Name[3-(6-bromo-4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[3-[4-bromo-3-(trifluoromethyl)pyrazol-1-yl]pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(6-chloropyrazolo[5,4-b]pyridin-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;N-[1-(1H-imidazole-5-carbonyl)pyrrolidin-3-yl]cyclopropanecarboxamide;[(3R)-3-indazol-1-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-indazol-2-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone
PubChem CID158780325
Molecular FormulaC116H133Br2ClF5N35O8
Molecular Weight2435.83 g/mol
Exact Mass2431.91
IUPAC Name[3-(6-bromo-4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[3-[4-bromo-3-(trifluoromethyl)pyrazol-1-yl]pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(6-chloropyrazolo[5,4-b]pyridin-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;N-[1-(1H-imidazole-5-carbonyl)pyrrolidin-3-yl]cyclopropanecarboxamide;[(3R)-3-indazol-1-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-indazol-2-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone
SMILESCC(C)c1cc(C(=O)N2CCC(n3cc(Br)c(C(F)(F)F)n3)C2)n[nH]1.CC(C)c1cc(C(=O)N2CCC(n3ncc4c(F)cc(Br)cc43)C2)n[nH]1.CC(C)c1cc(C(=O)N2CC[C@@H](n3cc4ccccc4n3)C2)n[nH]1.CC(C)c1cc(C(=O)N2CC[C@@H](n3ncc4c(F)cccc43)C2)n[nH]1.CC(C)c1cc(C(=O)N2CC[C@@H](n3ncc4ccc(Cl)nc43)C2)n[nH]1.CC(C)c1cc(C(=O)N2CC[C@@H](n3ncc4ccccc43)C2)n[nH]1.O=C(NC1CCN(C(=O)c2cnc[nH]2)C1)C1CC1
InChIInChI=1S/C18H19BrFN5O.C18H20FN5O.2C18H21N5O.C17H19ClN6O.C15H17BrF3N5O.C12H16N4O2/c1-10(2)15-7-16(23-22-15)18(26)24-4-3-12(9-24)25-17-6-11(19)5-14(20)13(17)8-21-25;1-11(2)15-8-16(22-21-15)18(25)23-7-6-12(10-23)24-17-5-3-4-14(19)13(17)9-20-24;1-12(2)15-9-16(21-20-15)18(24)22-8-7-14(11-22)23-17-6-4-3-5-13(17)10-19-23;1-12(2)16-9-17(20-19-16)18(24)22-8-7-14(11-22)23-10-13-5-3-4-6-15(13)21-23;1-10(2)13-7-14(22-21-13)17(25)23-6-5-12(9-23)24-16-11(8-19-24)3-4-15(18)20-16;1-8(2)11-5-12(21-20-11)14(25)23-4-3-9(6-23)24-7-10(16)13(22-24)15(17,18)19;17-11(8-1-2-8)15-9-3-4-16(6-9)12(18)10-5-13-7-14-10/h5-8,10,12H,3-4,9H2,1-2H3,(H,22,23);3-5,8-9,11-12H,6-7,10H2,1-2H3,(H,21,22);3-6,9-10,12,14H,7-8,11H2,1-2H3,(H,20,21);3-6,9-10,12,14H,7-8,11H2,1-2H3,(H,19,20);3-4,7-8,10,12H,5-6,9H2,1-2H3,(H,21,22);5,7-9H,3-4,6H2,1-2H3,(H,20,21);5,7-9H,1-4,6H2,(H,13,14)(H,15,17)/t;12-;2*14-;12-;;/m.1111../s1
InChIKeyIQZKDBQLEGFWBE-JMSZYTPJSA-N
XLogP19.69
TPSA491.84 Ų
H-Bond Donors8
H-Bond Acceptors28
Rotatable Bonds21
Heavy Atoms167
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002435.83
LogP ≤ 519.69
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1028

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze [3-(6-bromo-4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[3-[4-bromo-3-(trifluoromethyl)pyrazol-1-yl]pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(6-chloropyrazolo[5,4-b]pyridin-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;N-[1-(1H-imidazole-5-carbonyl)pyrrolidin-3-yl]cyclopropanecarboxamide;[(3R)-3-indazol-1-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-indazol-2-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [3-(6-bromo-4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[3-[4-bromo-3-(trifluoromethyl)pyrazol-1-yl]pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(6-chloropyrazolo[5,4-b]pyridin-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;N-[1-(1H-imidazole-5-carbonyl)pyrrolidin-3-yl]cyclopropanecarboxamide;[(3R)-3-indazol-1-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-indazol-2-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone?
The IUPAC name of [3-(6-bromo-4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[3-[4-bromo-3-(trifluoromethyl)pyrazol-1-yl]pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(6-chloropyrazolo[5,4-b]pyridin-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;N-[1-(1H-imidazole-5-carbonyl)pyrrolidin-3-yl]cyclopropanecarboxamide;[(3R)-3-indazol-1-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-indazol-2-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone (CID 158780325) is [3-(6-bromo-4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[3-[4-bromo-3-(trifluoromethyl)pyrazol-1-yl]pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(6-chloropyrazolo[5,4-b]pyridin-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;N-[1-(1H-imidazole-5-carbonyl)pyrrolidin-3-yl]cyclopropanecarboxamide;[(3R)-3-indazol-1-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-indazol-2-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone.
What is the SMILES notation for [3-(6-bromo-4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[3-[4-bromo-3-(trifluoromethyl)pyrazol-1-yl]pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(6-chloropyrazolo[5,4-b]pyridin-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;N-[1-(1H-imidazole-5-carbonyl)pyrrolidin-3-yl]cyclopropanecarboxamide;[(3R)-3-indazol-1-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-indazol-2-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone?
The canonical SMILES for [3-(6-bromo-4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[3-[4-bromo-3-(trifluoromethyl)pyrazol-1-yl]pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(6-chloropyrazolo[5,4-b]pyridin-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;N-[1-(1H-imidazole-5-carbonyl)pyrrolidin-3-yl]cyclopropanecarboxamide;[(3R)-3-indazol-1-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-indazol-2-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone is CC(C)c1cc(C(=O)N2CCC(n3cc(Br)c(C(F)(F)F)n3)C2)n[nH]1.CC(C)c1cc(C(=O)N2CCC(n3ncc4c(F)cc(Br)cc43)C2)n[nH]1.CC(C)c1cc(C(=O)N2CC[C@@H](n3cc4ccccc4n3)C2)n[nH]1.CC(C)c1cc(C(=O)N2CC[C@@H](n3ncc4c(F)cccc43)C2)n[nH]1.CC(C)c1cc(C(=O)N2CC[C@@H](n3ncc4ccc(Cl)nc43)C2)n[nH]1.CC(C)c1cc(C(=O)N2CC[C@@H](n3ncc4ccccc43)C2)n[nH]1.O=C(NC1CCN(C(=O)c2cnc[nH]2)C1)C1CC1.
What is the InChIKey of [3-(6-bromo-4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[3-[4-bromo-3-(trifluoromethyl)pyrazol-1-yl]pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(6-chloropyrazolo[5,4-b]pyridin-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;N-[1-(1H-imidazole-5-carbonyl)pyrrolidin-3-yl]cyclopropanecarboxamide;[(3R)-3-indazol-1-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-indazol-2-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone?
The InChIKey is IQZKDBQLEGFWBE-JMSZYTPJSA-N. The full InChI is InChI=1S/C18H19BrFN5O.C18H20FN5O.2C18H21N5O.C17H19ClN6O.C15H17BrF3N5O.C12H16N4O2/c1-10(2)15-7-16(23-22-15)18(26)24-4-3-12(9-24)25-17-6-11(19)5-14(20)13(17)8-21-25;1-11(2)15-8-16(22-21-15)18(25)23-7-6-12(10-23)24-17-5-3-4-14(19)13(17)9-20-24;1-12(2)15-9-16(21-20-15)18(24)22-8-7-14(11-22)23-17-6-4-3-5-13(17)10-19-23;1-12(2)16-9-17(20-19-16)18(24)22-8-7-14(11-22)23-10-13-5-3-4-6-15(13)21-23;1-10(2)13-7-14(22-21-13)17(25)23-6-5-12(9-23)24-16-11(8-19-24)3-4-15(18)20-16;1-8(2)11-5-12(21-20-11)14(25)23-4-3-9(6-23)24-7-10(16)13(22-24)15(17,18)19;17-11(8-1-2-8)15-9-3-4-16(6-9)12(18)10-5-13-7-14-10/h5-8,10,12H,3-4,9H2,1-2H3,(H,22,23);3-5,8-9,11-12H,6-7,10H2,1-2H3,(H,21,22);3-6,9-10,12,14H,7-8,11H2,1-2H3,(H,20,21);3-6,9-10,12,14H,7-8,11H2,1-2H3,(H,19,20);3-4,7-8,10,12H,5-6,9H2,1-2H3,(H,21,22);5,7-9H,3-4,6H2,1-2H3,(H,20,21);5,7-9H,1-4,6H2,(H,13,14)(H,15,17)/t;12-;2*14-;12-;;/m.1111../s1.
What are the key properties of [3-(6-bromo-4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[3-[4-bromo-3-(trifluoromethyl)pyrazol-1-yl]pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(6-chloropyrazolo[5,4-b]pyridin-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;N-[1-(1H-imidazole-5-carbonyl)pyrrolidin-3-yl]cyclopropanecarboxamide;[(3R)-3-indazol-1-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-indazol-2-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone?
[3-(6-bromo-4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[3-[4-bromo-3-(trifluoromethyl)pyrazol-1-yl]pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(6-chloropyrazolo[5,4-b]pyridin-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;N-[1-(1H-imidazole-5-carbonyl)pyrrolidin-3-yl]cyclopropanecarboxamide;[(3R)-3-indazol-1-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-indazol-2-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone has a molecular weight of 2435.83 g/mol, XLogP of 19.69, 21 rotatable bonds, 8 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for [3-(6-bromo-4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[3-[4-bromo-3-(trifluoromethyl)pyrazol-1-yl]pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(6-chloropyrazolo[5,4-b]pyridin-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-(4-fluoroindazol-1-yl)pyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;N-[1-(1H-imidazole-5-carbonyl)pyrrolidin-3-yl]cyclopropanecarboxamide;[(3R)-3-indazol-1-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone;[(3R)-3-indazol-2-ylpyrrolidin-1-yl]-(5-propan-2-yl-1H-pyrazol-3-yl)methanone is sourced from PubChem (CID 158780325), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).